Comments
Commented by André Will-Laudien on May 8th, 2025 | 07:10 CEST
Almonty Industries – The next 100% opportunity with strategic metals
Things continue to go well for Almonty Industries (TSX: AII; WKN: A1JSSD; ISIN: CA0203981034; EUR 1.59). The stock is already one of the best commodity stocks for 2025. The market is gradually realizing that this story could be worth billions. The trade dispute between the US and many nations is proving to be a death blow for Western industries, especially those in China. In response to announced trade tariffs of over 100%, the leadership in Beijing has imposed export restrictions on strategic metals. Tungsten is one of the most critical metals, essential for high-tech and defense applications. Deposits and producers are few and far between, with a good 70% of supply coming from China. Almonty Industries is set to start production in South Korea in 2025, and US producers are already securing valuable tungsten. A jump in valuation is on the cards!
Read
Commented by Armin Schulz on May 8th, 2025 | 07:05 CEST
Cancer revolution: How Bayer, Vidac Pharma, and Pfizer are shaking up the billion-dollar market
Oncology has become the scene of an unprecedented competition. Where billion-dollar markets meet life-saving innovations, a global playing field for pioneers is emerging. Forecasts show that therapy costs and market volume are growing exponentially. This poses a challenge for healthcare systems and represents a gold mine for visionaries. New technologies such as personalized cancer vaccines and targeted drugs are pushing the boundaries of what is possible. Three players are strategically positioning themselves in this dynamic environment: Bayer, Vidac Pharma, and Pfizer. Their next moves could shape not only patients' lives, but entire industries.
Read
Commented by Nico Popp on May 8th, 2025 | 07:00 CEST
Data as a return booster: NetraMark, BioNTech, and Palantir Technologies
It is common knowledge by now that data is the raw material of the 21st century. However, only a few truly understand the many ways in which this digital raw material can now be processed. Today, we present three companies - NetraMark, BioNTech, and Palantir Technologies - whose business models stand to benefit significantly from modern data processing and AI. We also examine whether there is any potential for collaboration between these companies.
Read
Commented by André Will-Laudien on May 7th, 2025 | 09:55 CEST
High-grade discovery at Tocvan Ventures – Gold corridor within reach at Gran Pilar
Volatility on the capital markets reached record levels in the first quarter of 2025. Geopolitical upheavals and unpredictable US policy have caused stock prices to fluctuate wildly. Precious metal investments could provide a good hedge against turbulence in the financial system and a devaluation of the US dollar. With spot prices recently reaching new record highs, investors are increasingly strengthening their exposure to the commodities sector. Gold has so far met expectations with prices of up to USD 3,500 and an annual gain of just under 20% in 2025, while silver has also reached high prices of over USD 35. In addition to producers, the spotlight is now shifting to the second tier of explorers. This is because the valuations of in-ground resources are at their lowest level in decades. Canadian gold explorer Tocvan Ventures (CSE: TOC | WKN: A2PE64 | ISIN: CA88900N1050 | CAD 0.69) has recently seen a string of positive announcements. The latest update on recent drilling at the Pilar gold-silver project in Sonora delivered impressive gold and silver grades.
Read
Commented by Armin Schulz on May 7th, 2025 | 07:10 CEST
Evotec's AI gold mine, Defence Therapeutics' billion-dollar markets, Novo Nordisk's diet revolution: How investors are profiting
The healthcare industry is undergoing radical change. Algorithms are accelerating drug discovery by years, billions are being poured into personalized therapies, and biotech stocks are celebrating on the stock markets. But this time, it is not just short-lived hype – the next era of medicine will be shaped by companies merging technology and biology. While AI-based platforms identify drug candidates in record time, pioneers are pushing ahead with groundbreaking approaches in oncology, immunology, and metabolic diseases. Three names stand out: Evotec, Defence Therapeutics, and Novo Nordisk.
Read
Commented by Fabian Lorenz on May 7th, 2025 | 07:05 CEST
While Friedrich Merz fails, BUYING OPPORTUNITIES arise for these stocks: Deutz, BYD, and Power Metallic Mines
Friedrich Merz has failed in the first round of voting to become Chancellor. But these stocks are winners: without metals, there would be no electromobility, no defense, no infrastructure - and when it comes to gold, no store of value. Power Metallic Metals caused a stir last year with spectacular drilling results. The latest samples show that the potential is far from exhausted. The current consolidation of the stock should soon be over. Deutz has already demonstrated how quickly a stock can explode. Analysts believe there is even more upside potential! And what is BYD doing? The Chinese company is growing strongly in their home market. In Europe, a bestseller is now set to bring success. Is this a threat to Volkswagen?
Read
Commented by Nico Popp on May 7th, 2025 | 07:00 CEST
Will dynaCERT save German industry?
The future is traded on the stock market. However, while prototypes and small-scale production fuel investor imagination, only concrete orders generate profits. Canadian hydrogen company dynaCERT is currently in an exciting phase. The Company went on a customer acquisition drive at the Munich construction and mining trade fair (Bauma). Find out what events are planned for the coming weeks and months and which industries, particularly in Germany, are being considered potential partners for dynaCERT.
Read
Commented by Nico Popp on May 6th, 2025 | 07:10 CEST
Almonty: Why tungsten is the most critical of all metals
Tungsten producer Almonty Industries shares are among this year's high flyers - rising from EUR 0.61 to EUR 1.56. There are many reasons for this: the imminent opening of Almonty's Sangdong mine in South Korea comes at a time of extreme geopolitical volatility, including a tariff and raw materials war and the gradual erosion of NATO. However, there are further reasons why tungsten is currently in such high demand. What role does China play in this, and do stocks like Almonty still hold more upside potential?
Read
Commented by Armin Schulz on May 6th, 2025 | 07:05 CEST
Soil boosters wanted! The secret weapons of Bayer, Argo Living Soils, and K+S
Agriculture is at a crossroads between tradition and revolution. While optimistic forecasts like the Iowa Crop Progress Report 2025 predict record-breaking harvests, a paradoxical conflict is emerging. Blooming fields conceal depleting soils and climate stress. But this is precisely where the tension for innovation unfolds - where high-tech meets sustainability. Three players are helping to shape this future: Bayer as a pioneer of digital agricultural solutions; Argo Living Soils with revolutionary soil savers; and K+S, which is rethinking mineral fertilizers. Together, they are not only securing harvests but also healing ecosystems.
Read
Commented by Stefan Feulner on May 6th, 2025 | 07:00 CEST
Strategy, 123fahrschule, BASF – Massive increases
Amid high volatility, Germany's leading index, the DAX, regained the psychologically important 23,000-point mark after its setback in April. Investors are betting on an imminent resolution to US President Donald Trump's erratic tariff policies. Small caps also posted significant gains after the drastic losses in the previous month. Many companies remain undervalued, offering further upside potential.
Read